EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID ‐19 pandemic, 2013–2021: a retrospective cohort study

Stephen J Wood, Jenni Ilomäki, Jacqueline Gould, George Sq Tan, Melissa Raven iD, Jon N Jureidini iD, Luke E Grzeskowiak iD

Medical Journal of Australia · 03.07.2023 · 219 (1) · 18-25

DOI: 10.5694/mja2.51948 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Medical Journal of Australia, online erschienen am 14.05.2023. Verfasst von Stephen J Wood und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Medicine Use and Safety, Monash University, Melbourne, VIC. Hauptthemen laut MEDLINE: COVID-19, Central Nervous System Stimulants. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Channel 7 Children's Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine longitudinal patterns of dispensing of antidepressant, anxiolytic, antipsychotic, psychostimulant, and hypnotic/sedative medications to children and adolescents in Australia during 2013–2021.

Design

Retrospective cohort study; analysis of 10% random sample of Pharmaceutical Benefits Scheme (PBS) dispensing data. Participants, setting People aged 18 years or younger dispensed PBS‐subsidised psychotropic medications in Australia, 2013–2021. Main outcome measures Population prevalence of dispensing of psychotropic medications to children and adolescents, by psychotropic class, gender, and age group (0–6, 7–12, 13–18 years).

Results

The overall prevalence of psychotropic dispensing to children and adolescents was 33.8 per 1000 boys and 25.2 per 1000 girls in 2013, and 60.0 per 1000 boys and 48.3 per 1000 girls in 2021. The prevalence of psychotropic polypharmacy was 5.4 per 1000 boys and 3.7 per 1000 girls in 2013, and 10.4 per 1000 boys and 8.3 per 1000 girls in 2021. Prevalent dispensing during 2021 was highest for psychostimulants (boys, 44.0 per 1000; girls, 17.4 per 1000) and antidepressants (boys, 20.4 per 1000; girls, 33.8 per 1000). During 2021, the prevalence of dispensing was higher than predicted by extrapolation of 2013–2019 data for many classes, including antidepressants (boys: +6.1%; 95% CI, 1.1–11.1%; girls: +22.2%; 95% CI, 17.4–26.9%), and psychostimulants (boys: +14.5%; 95% CI, 8.0–21.1%; girls: +27.7%; 95% CI, 18.9–36.6%). The increases were greatest for girls aged 13–18 years (antidepressants: +20.3%; 95% CI, 16.9–23.7%; psychostimulants: +39.0%; 95% CI, 27.9–50.0%).

Conclusions

The prevalence of both psychotropic dispensing and psychotropic polypharmacy for children and adolescents were twice as high in 2021 as in 2013. The reasons and appropriateness of the marked increases in psychotropic dispensing during the COVID‐19 pandemic, particularly to adolescent girls, should be investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Central Nervous System StimulantsMaleFemaleHumansChildAdolescentRetrospective StudiesPandemicsAustraliaPsychotropic DrugsAntidepressive Agents

Stichwörter der Autor:innen

COVID-19Child psychiatryPediatricsPharmacoepidemiologyPrescribingPsychotropic drugs

Substanzen

Psychotropic DrugsAntidepressive AgentsCentral Nervous System Stimulants

Autor:innen und Institutionen

  • Centre for Medicine Use and Safety, Monash University, Melbourne, VIC.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC.
  • South Australian Health and Medical Research Institute, Adelaide, SA.
  • Robinson Research Institute, University of Adelaide, Adelaide, SA.
  • College of Medicine and Public Health, Flinders University, Adelaide, SA.

ORCID-Profile: Melissa Raven, Jon N Jureidini, Luke E Grzeskowiak

Förderung

  • Channel 7 Children's Research Foundation

Zitieren

APA

Wood, S. J., Ilomäki, J., Gould, J., Tan, G. S., Raven, M., Jureidini, J. N., & Grzeskowiak, L. E. (2023). Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID ‐19 pandemic, 2013–2021: a retrospective cohort study. Medical Journal of Australia, 219(1), 18-25. https://doi.org/10.5694/mja2.51948

Vancouver

Wood SJ, Ilomäki J, Gould J, Tan GS, Raven M, Jureidini JN, et al. Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID ‐19 pandemic, 2013–2021: a retrospective cohort study. Medical Journal of Australia. 2023;219(1):18-25. doi:10.5694/mja2.51948

BibTeX
@article{Wood2023,
  author = {Wood, Stephen J and Ilomäki, Jenni and Gould, Jacqueline and Tan, George Sq and Raven, Melissa and Jureidini, Jon N and Grzeskowiak, Luke E},
  title = {Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID ‐19 pandemic, 2013–2021: a retrospective cohort study},
  journal = {Medical Journal of Australia},
  year = {2023},
  volume = {219},
  number = {1},
  pages = {18--25},
  doi = {10.5694/mja2.51948}
}
Kostenlos starten →